POOLBEG PHARMA PLC (POLB) — Company Presentation

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the POLBEG PHARMA PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be submitted at any time via the Q and A tab situated on the right hand corner of your screen. Please just simply type in your questions and press send. Before we begin, I'd like to submit the following poll. Now I'd like to hand you over to Jeremy Skeleton, CEO. Good afternoon, sir. Good afternoon, and thank you for the introduction. And thank you everybody for joining us this afternoon for the POOLBEG presentation, of course, on the back of our r and s this morning talking about the interim results. Again, we have a fantastic presentation to go through to kind of update you on that. I'm delighted to be joined by my colleagues, Liam Tremblen, Ian O'Connell, and, we'll kick off, and, let's go through this. So as I say, we're we've got the a team with us today. I'll talk about the background, talk about the the companies that kinda set the scene. Liam will talk more about the clinical trial, the topical clinical trial. Let's say we've kinda announced the the positive interim data this morning. We're all delighted with that just as things are moving. We've got some terrific momentum now, so we're looking to kind of execute. And then I will Ian will speak more about the the commercial opportunity that we have here because, ultimately, we're looking for partners and partner in the program. So we'll talk a little bit about that. So again, to set the scene, POOLBEG PHARMA, clinical stage company. We're developing POLB001 to potentially transform the lives of cancer patients, to allow them to have their cancer immunotherapy treatment safe and locally. And by doing that, we're preventing C...